US 11905285
Inhibitors of plasma kallikrein and uses thereof
granted A61PA61P7/10
Quick answer
US patent 11905285 (Inhibitors of plasma kallikrein and uses thereof) held by Takeda Pharmaceutical Company Limited expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P7/10